XML 26 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Note 4 - Marketable Equity Securities
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
4.
MARKETABLE EQUITY SECURITIES
 
The Company accounts for its marketable securities in accordance with ASC Topic
321,
Investments - Equity Securities. ASC Topic
321
requires companies to measure equity investments at fair value, with changes in fair value recognized in net income. The Company’s investments in marketable securities consist of equity securities with readily determinable fair values. The cost of securities sold is based on the specific identification method, and interest and dividends on securities are included in non-operating income (expense).
 
Marketable equity securities are carried at fair value, with changes in fair market value included in the determination of net income. The fair market value of marketable equity securities is determined based on quoted market prices in active markets. See Note
18
– Fair Value of Financial Instruments for additional information regarding the valuation of marketable equity securities.
 
The following table sets forth cost, market value and unrealized gain on equity securities classified as available-for-sale as of
December 31, 2019
and
2018.
 
   
201
9
   
201
8
 
   
(in thousands)
 
Available-for-sale securities:
               
Fair market value
  $
29,521
    $
27,549
 
Cost
   
24,156
     
25,602
 
Unrealized gain
  $
5,365
    $
1,947
 
 
The following table sets forth the gross unrealized gains and losses on the Company’s marketable securities as of
December 31, 2019
and
2018.
 
   
201
9
   
201
8
 
   
(in thousands)
 
Available-for-sale securities:
               
Gross unrealized gains
  $
7,808
    $
5,668
 
Gross unrealized losses
   
2,443
     
3,721
 
Net unrealized gains
  $
5,365
    $
1,947
 
 
For the years ended
December 31, 2019,
2018
and
2017,
the Company recognized dividends of approximately
$1,309,000,
$1,171,000,
and
$999,000
in non-operating income in its statements of operations, respectively.
 
The following table shows the Company’s net realized gains during
2019,
2018
and
2017
on certain marketable equity securities.
 
   
201
9
   
201
8
   
201
7
 
   
(in thousands)
 
Realized gains:
                       
Sale proceeds
  $
2,984
    $
1,044
    $
6,833
 
Cost of securities sold
   
1,929
     
669
     
2,098
 
                         
Realized gains
  $
1,055
    $
375
    $
4,735
 
                         
Realized gains, net of taxes
  $
815
    $
278
    $
2,938
 
 
At
December 31, 2019,
the Company’s investments’ approximate fair value of securities in a loss position and related gross unrealized losses were
$8,587,000
and
$2,443,000,
respectively. At
December 31, 2018,
the Company’s investments’ approximate fair value of securities in a loss position and related gross unrealized losses were
$12,399,000
and
$3,721,000,
respectively.
 
The market value of the Company’s equity securities are periodically used as collateral against any outstanding margin account borrowings. As of
December 31, 2019
and
2018,
the Company had outstanding borrowings of
$7,474,000
and
$11,281,000
under its margin account, respectively, which is reflected in accrued expenses. The interest rate on margin account borrowings was
2.40%
and
3.11%
as of
December 31, 2019
and
2018,
respectively.